Cynosure (CYNO) Signs Multi-Yr Agreement with Unilever to Develop Light-Based Devices for Home Use
More News related to CYNO
- Cynosure (CYNO) Posts Q3 Loss of $0.15
- Cynosure Reports Third Quarter 2009 Financial Results
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Cynosure Enhances Industry-Leading Smartlipo Family with 1440 nm Wavelength
- Cynosure to Announce Third-Quarter 2009 Financial Results on October 27
More News related to Corporate News
- XOMA (XOMA) Falls Modestly Following After-Hours Downgrade
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- Natixis Bleichroeder Downgrades Tenaris S.A. (TS) to Reduce
- Bank of America Downgrades Seneca Foods (SENEB) from Buy
- RBC Downgrades Intrepid Potash (IPI) to Sector Perform
Cynosure, Inc. (Nasdaq: CYNO) today announced that it has signed a multi-year, funded cooperative agreement with Unilever Ltd. to develop and commercialize light-based devices targeting the home use personal care market. Financial terms of the agreement were not disclosed.
Related Categories
Corporate NewsStocks Mentioned
-0.23Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
